Home > Insider Trading > Filing (0001104659-24-024609)

Filing Details

Accession Number:: 0001104659-24-024609
Form Type:: 4/A
Zero Holdings:: No
Publication Time:: 2024-02-15 18:37:01
Reporting Period:: 2022-11-14

Accepted Time:: 2024-02-15 18:37:01
Original Submission Date:: 2022-11-16
SEC Url:: Form 4 Filing

Issuer

Cik	Name	Symbol	Sector (SIC)	IRS No
1622879	Medicine Man Technologies Inc.	SHWZ	Services-Management Consulting Services (8742)	465289499

Insiders

Cik	Name	Reported Address	Insider Title	Director	Officer	Large Shareholder	Other
1654539	Justin Dye	C/O Medicine Man Technologies, Inc. 865 N. Albion St., Ste 300 Denver CO 80220		Yes	No	Yes	No

Reported Non-Derivative Transactions

Show Other Fields >>

Sec. Name	Acquisiton - Disposition	Date	Amount	Price	Remaning Holdings	Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
Common Stock	Acquisiton	2022-11-15	198,484	$1.57	489,452	No	4	A	Direct
Common Stock	Acquisiton	2023-02-13	500,000	$1.50	500,000	No	4	P	Indirect	See footnote
Common Stock	Acquisiton	2023-09-29	130,801	$0.00	1,616,363	No	4	A	Direct

Equity Swap Involved	Form Type	Code	Nature of Ownership	Explanation
No	4	A	Direct
No	4	P	Indirect	See footnote
No	4	A	Direct

Footnotes

On November 14, 2022, the reporting person filed a Form 4 that erroneously reported a purchase of 187,484 of shares of Common Stock on November 15, 2022. In fact, as reported in this amendment, the purchase made on November 15, 2022, involved 198,484 shares of common stock. This filing properly reflects the correct number of shares acquired and beneficially owned by the reporting person in and following the reported transaction.
The reported price in Column 4 is a weighted average purchase price. These shares were purchased in multiple transactions at prices ranging from $1.34 to $1.74 per share. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer, or the staff of the Securities Exchange Commission, upon request, full information regarding the numbers of shares purchased at each separate price within the range set forth in this footnote.
On February 15, 2023, the reporting person filed a Form 4 that erroneously reported a purchase of 500,000 of Common Stock on February 13, 2023, as directly owned by the reporting person. In fact, as reported in this amendment, the purchase made on February 13, 2024, represents shares of common stock held by Dye Capital LLLP ("Dye LLLP"). As the managing partner of Dye LLLP, Mr. Dye has voting and investment control over the securities held by Dye LLLP. Mr. Dye disclaims beneficial ownership of the reported shares except to the extent of his pecuniary interest therein. This filing properly reflects the correct number of shares acquired and beneficially owned by the reporting person in and following the reported transaction.
The issuer granted the reporting person shares of common stock with an aggregate value of $103,333 (based on the closing price of the common stock on the OTCQX Best Market on September 29, 2023) for services on the board of directors.
On October 6, 2023, the reporting person filed a Form 4 that erroneously reported the Amount of Securities Beneficially Owned Following Reported Transaction of 1,998,863 shares of Common Stock directly owned by the reporting person. In fact, as reported in this amendment, the Amount of Securities Beneficially Owned Following Reported Transaction involved 1,616,363 shares of Common Stock. This filing properly reflects the correct number of shares acquired and beneficially owned, directly, by the reporting person in and following the reported transaction.